These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12481388)

  • 1. [Treatment of hepatitic C virus infection after the French 2002 Consensus Conference].
    Cacoub P
    Rev Med Interne; 2002 Nov; 23(11):889-92. PubMed ID: 12481388
    [No Abstract]   [Full Text] [Related]  

  • 2. PegIFN/ribavirin during acute HCV coinfection.
    Bernard EJ
    IAPAC Mon; 2004 Jul; 10(7):260-1. PubMed ID: 15624247
    [No Abstract]   [Full Text] [Related]  

  • 3. [Information for patients. Treatment of acute hepatitis C].
    Otón Nieto E
    Rev Esp Enferm Dig; 2011 Oct; 103(10):549. PubMed ID: 22054273
    [No Abstract]   [Full Text] [Related]  

  • 4. Co-infections. German doctors treat hepatitis C early, with some success.
    TreatmentUpdate; 2006; 18(5):3-4. PubMed ID: 17209229
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV & hepatitis C: treatment.
    WORLD; 2002 May; (133):4-5. PubMed ID: 12064298
    [No Abstract]   [Full Text] [Related]  

  • 6. Delaying HCV treatment in HIV-positive patients.
    Carter M
    IAPAC Mon; 2005 May; 11(5):147. PubMed ID: 16201045
    [No Abstract]   [Full Text] [Related]  

  • 7. Adding telaprevir improves cure rate in patient with HCV infection.
    AIDS Patient Care STDS; 2010 Dec; 24(12):807. PubMed ID: 21188771
    [No Abstract]   [Full Text] [Related]  

  • 8. Second thoughts about secondary analyses.
    Ferenci P
    Dig Liver Dis; 2005 Oct; 37(10):805-7; author reply 808-9. PubMed ID: 16023903
    [No Abstract]   [Full Text] [Related]  

  • 9. Anterior ischemic optic neuropathy in a patient with hepatitis C treated with interferon-alpha and ribavirin.
    Knyazer B; Lifshitz T; Marcus M; Kratz A; Zlotnik A; Levy J
    Isr Med Assoc J; 2011 Apr; 13(4):251-3. PubMed ID: 21598818
    [No Abstract]   [Full Text] [Related]  

  • 10. "Hepatitis C (HCV) treatment is not a "one size fits all".
    Bukeirat FA; Bukeirat MM
    W V Med J; 2012; 108(2):20, 22-4. PubMed ID: 22655431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apical hypertrophic cardiomyopathy associated with HCV infection].
    Fomin VV; Nikulkina EN; Sedov VP; Girina SS; Doletskiĭ AA; Moiseev SV
    Ter Arkh; 2011; 83(1):59-62. PubMed ID: 21446205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telaprevir (Incivek) and boceprevir (Victrelis) for chronic hepatitis C.
    Med Lett Drugs Ther; 2011 Jul; 53(1369):57-9. PubMed ID: 21778964
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pericardial effusion associated to interferon in an immunocompetent patient].
    Velasco J; Oriñuela I; Sanjuán AZ; Ortiz de Zárate Z
    Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):749-50. PubMed ID: 20579776
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of Eradication of HCV on Hepatic Venous Pressure Gradient in HIV-Infected Patients With Compensated HCV-Related Cirrhosis.
    Sánchez-Conde M; Pérez-Latorre L; Rincón D; Miralles P; Catalina MV; López JC; Bañares R; Berenguer J
    J Acquir Immune Defic Syndr; 2015 Aug; 69(4):e142-4. PubMed ID: 25861016
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of sarcoidosis-associated chronic hepatitis C virus infection: course and treatment].
    Longueira Suárez R; Ammari I; Lamas Ferreiro JL; Sopeña Pérez-Argüelles B; Martínez-Vázquez C
    Rev Clin Esp; 2009; 209(7):358-9. PubMed ID: 19709544
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment duration for genotypes 2 and 3: still confusing after all these years.
    Jensen DM
    J Clin Gastroenterol; 2010 Sep; 44(8):527-8. PubMed ID: 20628314
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased Th1, Th17 and pro-fibrotic responses in hepatitis C-infected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirin.
    Jimenez-Sousa MA; Almansa R; de la Fuente C; Caro-Paton A; Ruiz L; Sanchez-Antolín G; Gonzalez JM; Aller R; Alcaide N; Largo P; Resino S; de Lejarazu RO; Bermejo-Martin JF
    Eur Cytokine Netw; 2010 Jun; 21(2):84-91. PubMed ID: 20483710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment with pegylated interferon and ribavirin in patients co-infected by human immunodeficiency virus and hepatitis C virus].
    Marcos Sánchez F; Albo Castaño MI; Casallo Blanco S
    Rev Clin Esp; 2007 Mar; 207(3):150-1; author reply 151-2. PubMed ID: 17397643
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis C].
    Pache I; Gonvers JJ
    Rev Med Suisse Romande; 2002 Oct; 122(10):507-12. PubMed ID: 12494784
    [No Abstract]   [Full Text] [Related]  

  • 20. Digestive Disease Week 2000 conference report: New treatments for chronic hepatitis C.
    Brown PJ; Neuman MG
    Can J Clin Pharmacol; 2001; 8(2):67-71. PubMed ID: 11493933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.